News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Human Genome Sciences, Inc. Appoints Greg Norden to Its Board of Directors
January 21, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ROCKVILLE, Md.--(BUSINESS WIRE)--Human Genome Sciences, Inc. (Nasdaq:HGSI) today announced that Greg Norden, former Senior Vice President and Chief Financial Officer of Wyeth, has been appointed to the HGS Board of Directors.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Weight Loss
Despite Novo’s Robust Oral Wegovy Launch, Access Remains a Challenge for Obesity Drugs
March 25, 2026
·
3 min read
·
Heather McKenzie
Manufacturing
UCB Investing $2B To Build Manufacturing Facility in Georgia
March 25, 2026
·
2 min read
·
Nick Paul Taylor
Mergers & acquisitions
Merck To Buy Terns, ‘Unprecedented’ Leukemia Drug for $6.7B as Keytruda Cliff Looms
March 25, 2026
·
3 min read
·
Tristan Manalac
Funding
RA Capital Looks to China for Next Startup To Put on SPAC Track to Nasdaq
March 25, 2026
·
2 min read
·
Tristan Manalac
